Economic burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States

被引:0
作者
Hernandez-Pastor, Luis [1 ]
Geurtsen, Jeroen [2 ]
Baugh, Bryan [3 ]
Khoury, Antoine C. El [4 ]
Kalu, Nnanya [5 ]
Krishnarajah, Girishanthy [5 ]
Gauthier-Loiselle, Marjolaine [6 ]
Bungay, Rebecca [6 ]
Cloutier, Martin [6 ]
Saade, Elie [7 ]
机构
[1] Janssen Pharmaceut NV, Beerse, Belgium
[2] Janssen Vaccines & Prevent BV, Leiden, Netherlands
[3] Janssen Res & Dev LLC, Raritan, NJ USA
[4] Janssen Global Serv LLC, Raritan, NJ USA
[5] Janssen Sci Affairs LLC, Titusville, NJ USA
[6] Anal Grp Inc, Montreal, PQ, Canada
[7] Case Western Reserve Univ, Dept Med, Cleveland, OH USA
关键词
RESISTANT BACTERIAL-INFECTIONS; SEPSIS; MORTALITY; TRENDS; COLI;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND: Although invasive Escherichia coli disease (IED) can lead to severe clinical outcomes, little is known about the associated medical resource use and cost burden of IED in US hospitals. OBJECTIVE: To comprehensively describe medical resource use and costs associated with IED during the initial IED event and over the subsequent 12 months.METHODS: Patients aged 60 years or older with 1 or more IED encounters were identified from the PINC AI Healthcare US hospital database (October 1, 2015, to March 31, 2020). The index encounter was defined as the first encounter with a positive E coli culture in a normally sterile site (group 1 IED) or positive E coli culture in urine with signs of sepsis (group 2 IED). Encounters with a positive culture from other bacteria or fungal pathogens were excluded. Outcomes were descriptively reported between admission and discharge for the index encounter and more than 1 -year post-index discharge. Medical resource use and costs included inpatient admissions and outpatient hospital services; costs were reported from a hospital's perspective (ie, charged amount) in 2021 USD.RESULTS: A total of 19,773 patients were identified (group 1 IED = 51.8%; group 2 IED = 48.2%). Mean age was 76.8 years, 67.4% were female, and 82.1% were White. Most index encounters were community-onset (94.3%) and led to hospitalization (96.5%) (mean inpatient days = 6.9 days). During the 1 -year post-index, 36.8% of patients had 1 or more all-cause hospitalizations. Mean [median] total all-cause hospital costs (as captured through the PINC AI Healthcare database) amounted to $16,760 [$11,340] during the index encounter and $10,942 [$804] during the 1 -year post-index; these costs were higher in the presence of sepsis and multidrug resistance and among hospital-onset IED.CONCLUSIONS: IED is associated with a substantial medical resource use and economic burden both during the initial encounter and over the following year in older adults. This highlights the critical need and potential benefits of preventive measures that may reduce the incidence of IED and associated economic burden.
引用
收藏
页码:873 / 883
页数:25
相关论文
共 31 条
[1]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[2]  
Antimicrobial Resistance Collaborators, 2022, Lancet, V400, pP2221, DOI [10.1016/S0140-6736(22)02185-7, DOI 10.1016/S0140-6736(22)02185-7]
[3]   Effect of Bacteremia in Elderly Patients With Urinary Tract Infection [J].
Artero, Arturo ;
Esparcia, Ana ;
Eiros, Jose M. ;
Madrazo, Manuel ;
Alberola, Juan ;
Nogueira, Jose M. .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 352 (03) :267-271
[4]   Epidemiology of Invasive Escherichia coli Infection and Antibiotic Resistance Status Among Patients Treated in US Hospitals: 2009-2016 [J].
Begier, Elizabeth ;
Rosenthal, Ning A. ;
Gurtman, Alejandra ;
Kartashov, Alex ;
Donald, Robert G. K. ;
Lockhart, Stephen P. .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (04) :565-574
[5]   Predictors and Health Care Utilization of Sepsis Post-Ureteroscopy in a US-Based Population: Results from the Endourological Society TOWER Collaborative [J].
Bhojani, Naeem ;
Paranjpe, Rutugandha ;
Cutone, Ben ;
Rojanasarot, Sirikan ;
Chew, Ben H. .
JOURNAL OF ENDOUROLOGY, 2022, 36 (11) :1411-1417
[6]   Extraintestinal Pathogenic Escherichia coli [J].
Biran, Dvora ;
Ron, Eliora Z. .
ESCHERICHIA COLI, A VERSATILE PATHOGEN, 2018, 416 :149-161
[7]   Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review [J].
Bonten, Marc ;
Johnson, James R. ;
van den Biggelaar, Anita H. J. ;
Georgalis, Leonidas ;
Geurtsen, Jeroen ;
de Palacios, Patricia Ibarra ;
Gravenstein, Stefan ;
Verstraeten, Thomas ;
Hermans, Peter ;
Poolman, Jan T. .
CLINICAL INFECTIOUS DISEASES, 2021, 72 (07) :1211-1219
[8]   Sepsis Among Medicare Beneficiaries: 3. The Methods, Models, and Forecasts of Sepsis, 2012-2018 [J].
Buchman, Timothy G. ;
Simpson, Steven Q. ;
Sciarretta, Kimberly L. ;
Finne, Kristen P. ;
Sowers, Nicole ;
Collier, Michael ;
Chavan, Saurabh ;
Oke, Ibijoke ;
Pennini, Meghan E. ;
Santhosh, Aathira ;
Wax, Marie ;
Woodbury, Robyn ;
Chu, Steve ;
Merkeley, Tyler G. ;
Disbrow, Gary L. ;
Bright, Rick A. ;
MaCurdy, Thomas E. ;
Kelman, Jeffrey A. .
CRITICAL CARE MEDICINE, 2020, 48 (03) :302-318
[9]   Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals [J].
Doua, Joachim ;
Geurtsen, Jeroen ;
Rodriguez-Bano, Jesus ;
Cornely, Oliver A. ;
Go, Oscar ;
Gomila-Grange, Aina ;
Kirby, Andrew ;
Hermans, Peter ;
Gori, Andrea ;
Zuccaro, Valentina ;
Gravenstein, Stefan ;
Bonten, Marc ;
Poolman, Jan ;
Sarnecki, Michal .
OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (02)
[10]   A nationwide population-based study of Escherichia coli bloodstream infections: incidence, antimicrobial resistance and mortality [J].
Feldman, Sarah F. ;
Temkin, Elizabeth ;
Wullfhart, Liat ;
Nutman, Amir ;
Schechner, Vered ;
Shitrit, Pnina ;
Shvartz, Racheli ;
Schwaber, Mitchell J. ;
Andremont, Antoine ;
Carmeli, Yehuda .
CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (06) :879.e1-879.e7